MAZE
NASDAQ · Pharmaceuticals
Maze Therapeutics Inc
$48.03
-1.40 (-2.83%)
Performance
1D
—
1W
—
1M
—
3M
+14.09%
6M
+90.60%
1Y
+346.38%
YTD
+20.77%
Open$49.31
Previous Close$49.43
Day High$50.70
Day Low$47.76
52W High$53.65
52W Low$6.71
Volume—
Avg Volume739.5K
Market Cap2.37B
P/E Ratio—
EPS$-1.20
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$42.71
Above
SMA 200
$25.83
Above
RSI (14)
50.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
12 analysts
Price Target
+95.5% upside
Current
$48.03
$48.03
Target
$93.90
$93.90
$74.59
$93.90 avg
$145.81
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 180.69M | 546.10M | 525.77M |
| Net Income | 19.82M | 109.70M | 88.79M |
| Profit Margin | 11.0% | 20.1% | 16.9% |
| EBITDA | 65.68M | 173.82M | 160.69M |
| Free Cash Flow | — | 65.89M | 67.30M |
| Rev Growth | — | +21.9% | +7.3% |
| Debt/Equity | — | 0.74 | 0.66 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |